ID: ALA4793744

Max Phase: Preclinical

Molecular Formula: C20H18N2O4S

Molecular Weight: 382.44

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  COc1ccccc1Sc1cccc2c1CN(C1CCC(=O)NC1=O)C2=O

Standard InChI:  InChI=1S/C20H18N2O4S/c1-26-15-6-2-3-7-17(15)27-16-8-4-5-12-13(16)11-22(20(12)25)14-9-10-18(23)21-19(14)24/h2-8,14H,9-11H2,1H3,(H,21,23,24)

Standard InChI Key:  ALXRJGQYOAICBX-UHFFFAOYSA-N

Associated Targets(Human)

MM1.S 1111 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

DNA-binding protein Ikaros 184 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Zinc finger protein Aiolos 4 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 382.44Molecular Weight (Monoisotopic): 382.0987AlogP: 2.61#Rotatable Bonds: 4
Polar Surface Area: 75.71Molecular Species: NEUTRALHBA: 5HBD: 1
#RO5 Violations: 0HBA (Lipinski): 6HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: 11.61CX Basic pKa: CX LogP: 2.15CX LogD: 2.15
Aromatic Rings: 2Heavy Atoms: 27QED Weighted: 0.82Np Likeness Score: -0.10

References

1. Wang Y,Mi T,Li Y,Kan W,Xu G,Li J,Zhou Y,Li J,Jiang X.  (2021)  Design, synthesis and biological evaluation of thioether-containing lenalidomide and pomalidomide derivatives with anti-multiple myeloma activity.,  209  [PMID:33328101] [10.1016/j.ejmech.2020.112912]

Source